CAD 2.1
(-7.89%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -229.47 Million CAD | -1506.65% |
2022 | -14.28 Million CAD | 89.22% |
2021 | -132.54 Million CAD | 2.65% |
2020 | -136.15 Million CAD | -1332.63% |
2019 | -9.5 Million CAD | -146.33% |
2018 | 20.51 Million CAD | 288.37% |
2017 | -10.88 Million CAD | -1386.19% |
2016 | 846.66 Thousand CAD | 166.31% |
2015 | -1.27 Million CAD | -433.56% |
2014 | -239.3 Thousand CAD | 36.23% |
2013 | -375.24 Thousand CAD | -167.72% |
2012 | -140.16 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -27.07 Million CAD | -71.9% |
2024 Q3 | 2.81 Million CAD | 110.41% |
2024 Q1 | -15.75 Million CAD | 52.26% |
2023 Q2 | -7.48 Million CAD | -240.51% |
2023 Q3 | -213.45 Million CAD | -2750.57% |
2023 Q4 | -32.99 Million CAD | 84.54% |
2023 Q1 | 5.32 Million CAD | 186.74% |
2023 FY | -229.47 Million CAD | -1506.66% |
2022 Q4 | -6.14 Million CAD | -120.45% |
2022 Q3 | -2.78 Million CAD | 31.13% |
2022 Q2 | -4.04 Million CAD | -210.11% |
2022 FY | -14.28 Million CAD | 89.22% |
2022 Q1 | -1.3 Million CAD | 94.98% |
2021 Q2 | -66.38 Million CAD | -93.35% |
2021 Q3 | -4 Million CAD | 93.96% |
2021 Q4 | -25.97 Million CAD | -547.98% |
2021 Q1 | -34.33 Million CAD | 11.02% |
2021 FY | -132.54 Million CAD | 2.65% |
2020 Q3 | -89.87 Million CAD | -1215.25% |
2020 Q4 | -38.59 Million CAD | 57.06% |
2020 FY | -136.15 Million CAD | -1332.63% |
2020 Q1 | -863 Thousand CAD | 96.16% |
2020 Q2 | -6.83 Million CAD | -691.77% |
2019 Q4 | -22.45 Million CAD | -120.57% |
2019 Q1 | 29.47 Million CAD | 63.62% |
2019 Q3 | -10.18 Million CAD | -59.41% |
2019 FY | -9.5 Million CAD | -146.33% |
2019 Q2 | -6.38 Million CAD | -121.66% |
2018 Q3 | 2.82 Million CAD | 162.08% |
2018 FY | 20.51 Million CAD | 288.37% |
2018 Q4 | 18.01 Million CAD | 538.9% |
2018 Q2 | 1.07 Million CAD | 176.76% |
2018 Q1 | -1.4 Million CAD | 31.06% |
2017 Q1 | -755.54 Thousand CAD | -220.91% |
2017 Q2 | -5.75 Million CAD | -661.73% |
2017 Q3 | -2.34 Million CAD | 59.24% |
2017 Q4 | -2.03 Million CAD | 13.31% |
2017 FY | -10.88 Million CAD | -1386.19% |
2016 Q3 | 367.72 Thousand CAD | 565.35% |
2016 Q4 | 624.88 Thousand CAD | 69.94% |
2016 FY | 846.66 Thousand CAD | 166.31% |
2016 Q1 | -201.21 Thousand CAD | -453.46% |
2016 Q2 | 55.26 Thousand CAD | 127.47% |
2015 Q2 | -634.93 Thousand CAD | 22.43% |
2015 Q1 | -818.53 Thousand CAD | -338.0% |
2015 Q4 | 56.92 Thousand CAD | -52.44% |
2015 FY | -1.27 Million CAD | -433.56% |
2015 Q3 | 119.69 Thousand CAD | 118.85% |
2014 Q4 | -186.88 Thousand CAD | -672.61% |
2014 Q2 | -15.69 Thousand CAD | 91.6% |
2014 Q1 | -186.75 Thousand CAD | -1373.63% |
2014 FY | -239.3 Thousand CAD | 36.23% |
2014 Q3 | -24.18 Thousand CAD | -54.13% |
2013 Q2 | -58.7 Thousand CAD | 76.78% |
2013 Q1 | -252.8 Thousand CAD | -315.97% |
2013 Q3 | -2962.00 CAD | 94.95% |
2013 Q4 | -12.67 Thousand CAD | -327.85% |
2013 FY | -375.24 Thousand CAD | -167.72% |
2012 FY | -140.16 Thousand CAD | 0.0% |
2012 Q3 | -43.44 Thousand CAD | 46.39% |
2012 Q2 | -81.03 Thousand CAD | -1168.18% |
2012 Q1 | -6390.00 CAD | 31.26% |
2012 Q4 | -60.77 Thousand CAD | -39.9% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | -9296.00 CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aurora Cannabis Inc. | -69.32 Million CAD | -231.013% |
Avicanna Inc. | -8.74 Million CAD | -2524.703% |
Avant Brands Inc. | -5.07 Million CAD | -4426.191% |
Cardiol Therapeutics Inc. | -28.12 Million CAD | -715.826% |
Crescita Therapeutics Inc. | -1.98 Million CAD | -11454.777% |
Knight Therapeutics Inc. | -16.83 Million CAD | -1263.1% |
MediPharm Labs Corp. | -13.08 Million CAD | -1654.016% |
Canopy Growth Corporation | -657.26 Million CAD | 65.086% |
Willow Biosciences Inc. | -13.02 Million CAD | -1661.285% |
Auxly Cannabis Group Inc. | -44.51 Million CAD | -415.553% |